"Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis(MS)."

"There is no cure for MS. However, there is an experimental treatment called Autologous Hematopoietic Stem Cell Transplantation (AHSCT). Advocates claim AHSCT can curb the debilitating symptoms of MS. Stem cell transplants were carried out to stop the disease progressing rather than repair what has already been damaged. As part of the process, stem cells are taken from the patient's bone marrow or peripheral blood and stored in sub-zero temperatures. The patient then undergoes a high dose of chemotherapy before the stem cells are replanted."

"Adipose-derived stem cells (AdSCs) have recently been considered a useful treatment tool for autoimmune disease because of their anti-inflammatory and immunosuppressive effects. We investigated the therapeutic effect of intravenous AdSC transplantation in a mouse model of bleomycin-induced lung injury. AdSCs accumulated in the pulmonary interstitium and inhibited both inflammation and fibrosis in the lung, markedly improving the survival rate of mice with bleomycin-induced lung injury in a cell number-dependent manner."

"Just six months ago, Jovon hovered near death, diagnosed with a rare immune disorder that had bounced him in and out of the hospital since his third birthday. His symptoms had ballooned from flu-like coughs and tiredness into seizures and a tumor blocking half his airway. Doctors at UHealth would find Jovon had cancer – stage 2 lymphoma – connected to X-linked lymphoproliferative syndrome, a literally one-in-a-million genetic disorder that made him vulnerable to certain infections."

"As the world of stem cell research advances, more options may become available to patients with RA and other autoimmune diseases."

"A year after her first stem cell treatment, Sarah has stopped her chemotherapy treatments and cut out almost all of her maintenance drugs. She has received several cycles of therapy, totaling 2.5 billion of her own stem cells since the initial treatment, and she will receive more in 2016. Her physicians will reevaluate Sarah in 2017 to see whether her immune system has learned to self-regulate after two years of stem cell therapy."

"So far, the treatment has restored immune systems in all 23 patients in the most recent clinical trials, including Evangelina."

"A discovery made by investigators from Beth Israel Deaconess Medical Center (BIDMC) and the Boston University School of Medicine (BUSM) may help lead to the development of a cell-based regenerative therapy which could be used to restore thyroid function in patients with cancer who have had their thyroids surgically removed and children born with congenital hypothyroidism."

"People with lupus, an autoimmune disease, suffer from fatigue, joint pain and swelling and also have a markedly increased risk of developing osteoporosis. Clinical trials have shown that receiving a transplant of mesenchymal stem cells can greatly improve the condition of lupus patients, yet it has not been clear why this treatment strategy works so well."

"Merit Cudkowicz, MD, Professor of Neurology at Harvard Medical School, Director of the ALS Clinical at Massachusetts General Hospital ALS Clinic, and a principal investigator for the trial, stated, "I want to thank the participants and their families for being part of this study and helping develop new therapies for ALS. Completion of enrollment is a very important milestone. We look forward to completing close follow-up and learning the results of this study."

"A recent study published in the journal Cell Transplantation revealed encouraging data on animal models for stem cell transplantation as a therapy for systemic lupus erythematosus (SLE). The study was led by researchers at the Hanyang University in Korea..."

"Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are one step closer to engineering a tool that could one day arm the body's immune system to fight HIV—and win. The new technique harnesses the regenerative capacity of stem cells to generate an immune response to the virus."

"Long-term follow-up of patients with fistulae related to Crohn’s disease demonstrated sustained complete closure after autologous adipose-derived stem cell therapy, according to research data."